NEW YORK CITY, NY / ACCESS Newswire / January 22, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Innodata Inc. ("Innodata" or "the Company") (NASDAQ:INOD). Investors who purchased Innodata securities prior to May 9, 2019, and continue to hold to the present, are encouraged to obtain additional […]

NEW YORK CITY, NY / ACCESS Newswire / January 22, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Quanex Building Products Corporation ("Quanex" or "the Company") (NYSE:NX). Investors who purchased Quanex securities prior to December 12, 2024, and continue to hold to the present, are encouraged to

NEW YORK, NY / ACCESS Newswire / January 22, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Digimarc Corporation ("Digimarc" or "the Company") (NASDAQ:DMRC). Investors who purchased Digimarc securities prior to May 3, 2024, and continue to hold to the present, are encouraged to obtain additional information

NEW YORK CITY, NY / ACCESS Newswire / January 22, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Pacira BioSciences, Inc. ("Pacira" or "the Company") (NASDAQ:PCRX). Investors who purchased Pacira securities prior to August 2, 2023, and continue to hold to the present, are encouraged to obtain

NEW YORK CITY, NY / ACCESS Newswire / January 22, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ibotta, Inc. ("Ibotta" or "the Company") (NYSE:IBTA). Investors who purchased Ibotta securities prior to April 18, 2024, and continue to hold to the present, are encouraged to obtain additional

NEW YORK CITY, NY / ACCESS Newswire / January 22, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lifecore Biomedical, Inc. ("Lifecore" or "the Company") (NASDAQ:LFCR). Investors who purchased Lifecore securities prior to October 7, 2020, and continue to hold to the present, are encouraged to obtain

NEW YORK, NY / ACCESS Newswire / January 22, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Nestlé S.A. ("Nestlé" or "the Company") (OTCMKTS:NSRGY). Investors who purchased Nestlé securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/NSRGY. Nestlé Investigation

(NYSE:KLAR), NEW ORLEANS, Jan. 22, 2026 (GLOBE NEWSWIRE) — ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 20, 2026 to file lead plaintiff applications in a securities class action lawsuit against Klarna Group plc (NYSE: KLAR), if they purchased the Company's securities pursuant and/or traceable to the registration statement and

Klarna Group Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Klarna Group plc – KLAR GlobeNewswire January 22, 2026 NEW ORLEANS, Jan. 22, 2026 (GLOBE NEWSWIRE) — ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 20, 2026 to

(NASDAQ:CRWV),(NYSE:ITGR),(NASDAQ:LFCR),(NASDAQ:VRNS), PHILADELPHIA, Jan. 22, 2026 (GLOBE NEWSWIRE) — CoreWeave, Inc. (NASDAQ: CRWV) Grabar Law Office is investigating claims on behalf of shareholders of CoreWeave, Inc. (NASDAQ: CRWV). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company. If you purchased CoreWeave, Inc. (NASDAQ: CRWV), on or near the